INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(12.53) per share. This is a 65.96 percent decrease over losses of $(7.55) per share from the same period last year. The company reported quarterly sales of $1.64 million which beat the analyst consensus estimate of $1.61 million by 1.93 percent. This is a 3.87 percent increase over sales of $1.58 million the same period last year.